Catalyst Pharmaceuticals Inc
CPRX
Market Cap$1.81B
Close$
$16.80
11.1% upside
Current Fair Value
11.1% upsideUndervalued by 11.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.81 Billion |
|---|---|
| Enterprise Value | $1.67 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.63 |
| Beta | 1.23 |
| Outstanding Shares | 118,011,092 |
| Avg 30 Day Volume | 1,079,319 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 25.35 |
|---|---|
| PEG | 68.89 |
| Price to Sales | 5.04 |
| Price to Book Ratio | 5.04 |
| Enterprise Value to Revenue | 4.2 |
| Enterprise Value to EBIT | 19.27 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Catalyst Pharmaceuticals Inc
CEO: Patrick McEnany